Caption Management, LLC Axsome Therapeutics, Inc. Put Options Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $2.28 Million - $3.21 Million	32,900 New	32,900 $2.63 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $146,025 - $225,875	-2,500 Reduced 8.33%	27,500 $1.98 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $291,950 - $375,000	-5,000 Reduced 14.29%	30,000 $1.85 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $1.4 Million - $2.79 Million	35,000 New	35,000 $2.7 Million
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $4.54 Million - $9.77 Million	-209,000 Reduced 91.27%	20,000 $766,000

Q1 2022 May 13, 2022	BUY	$23.7 - $41.39 $1.33 Million - $2.32 Million	56,000 Added 32.37%	229,000 $9.48 Million
Q3 2021 Nov 12, 2021	BUY	$19.91 - $68.26 $3.44 Million - $11.8 Million	173,000 New	173,000 $5.7 Million
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $15.3 Million - $30.2 Million	-306,400 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $12.6 Million - $31 Million	306,400 New	306,400 $18 Million

290

37.1M

401K

464K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.